Companies/THC Biomed Intl Ltd.

Company profile

THC Biomed Intl Ltd.

OTC: THCBF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Kelowna, BCReports USD

#793 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 37

v0.1 · 5/100 weight · pillars only

↑ 3-yr revenue growth, return on assets · ↓ growth stability, Piotroski F

Methodology →

Revenue TTM

$2.2M

Rev growth YoY (TTM)

-22.0%

Net income (FY)

-$2.4M

Employees

Market cap

$205.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.9M2.4M CAD2022

Net income-$2.4M-3.1M CAD2022

Operating income-$2.1M-2.7M CAD2022

Total assets$11.5M14.7M CAD2022

Liabilities$6.1M7.8M CAD2022

Equity$5.4M6.9M CAD2022

Revenue trend

FY2017 – FY2022 · USD

$45.2k

FY17

$726.5k

FY18

$1.1M

FY19

$3.1M

FY20

$3.0M

FY21

$1.9M

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

THC Biomed Intl Ltd. booked $1.9M in FY2022 revenue, contracting 35% year over year — slower than 78% of Healthcare companies we track, at a -125.2% net margin.

Peers · Healthcare

Ampio Pharmaceuticals, Inc.——THC Farmaceuticals, Inc.——Ultimate Sports, Inc.——ModivCare Inc.——

Key facts

CEOJohn Miller

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersKelowna, BC

ExchangeOTC: THCBF

Employees35

IPO date2018-03-16

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.